UK MHRA Consults On The Way For Personalized mRNA Cancer Therapies

 
• By Eliza Slawther
  
Cancer mRNA immunotherapies pose unique regulatory questions (Shutterstock)

More from Platform Technologies

More from Pathways & Standards